Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating
Craig-Hallum analyst Chase Knickerbocker maintains $Harrow(HROW.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 52.4% and a total average return of 11.9% over
Craig-Hallum Gives a Buy Rating to Harrow Health (HROW)
Harrow Health Unveils Performance Strategy to Investors
Harrow to Present at Three Investor Conferences in September in New York
B.Riley Financial Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $50
B.Riley Financial analyst Mayank Mamtani maintains $Harrow(HROW.US)$ with a buy rating, and maintains the target price at $50.According to TipRanks data, the analyst has a success rate of 27.7% and
Harrow Health's Promising Pipeline and Strategic Positioning Spur Buy Rating